Down-regulation of cyclin E1 expression by microrna-195 accounts for interferon-β-induced inhibition of hepatic stellate cell proliferation

Journal of Cellular Physiology

Volumn 226, Issue 10, 2011, Pages 2535-2542

  Sekiya, Yumiko ^a   Ogawa, Tomohiro ^a   Iizuka, Masashi ^a   Yoshizato, Katsutoshi ^a,b   Ikeda, Kazuo ^c   Kawada, Norifumi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b PhoenixBio USA Corporation   (Japan)

^c NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYCLIN E; CYCLIN E1; MESSENGER RNA; MICRORNA; MICRORNA 195; PROTEIN P21; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL; UPREGULATION;

ANIMALS; CELL LINE; CELL PROLIFERATION; CYCLIN E; DOWN-REGULATION; G1 PHASE; GROWTH INHIBITORS; HEPATIC STELLATE CELLS; HUMANS; INTERFERON-BETA; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; ONCOGENE PROTEINS; S PHASE;

EID: 79960682216     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22598     Document Type: Article

References (32)

1. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Bataller R, Brenner DA. 2001. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liv Dis 21: 437-451.
3. Chang XM, Chang Y, Jia A. 2005. Effects of interferon-alpha on expression of hepatic stellate cell and transforming growth factor-beta1 and alpha-smooth muscle actin in rats with hepatic fibrosis. World J Gastroenterol 11: 2634-2636.
4. Croze E, Russell-Harde D, Wagner TC, Pu H, Pfeffer LM, Perez HD. 1996. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein. J Biol Chem 271: 33165-33168.
5. Darnell JE, Kerr IM, Stark GR. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421.
6. Fort J, Pilette C, Veal N, Oberti F, Gallois Y, Douay O, Rosenbaum J, Cales P. 1998. Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats. J Hepatol 29: 263-270.
7. Friedman SL. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250.
8. Gartel AL, Tyner AL. 1999. Transcriptional regulation of the p21(WAF1/ClP1) gene. Exp Cell Res 246: 280-289.
9. Golias CH, Charalabopoulos A, Charalabopoulos K. 2004. Cell proliferation and cell cycle control: A mini review. Int J Clin Pract 58: 1134-1141.
10. Guo CJ, Pan Q, Jiang B, Chen GY, Li DG. 2009a. Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis 14: 1331-1340.
11. Guo CJ, Pan Q, Li DG, Sun H, Liu BW. 2009b. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis. J Hepatol 50: 766-778.
12. Inagaki Y, Nemoto T, Kushida M, Meng Y, Higashi K, Ikeda K, Kawada N, Shirasaki F, Takehara K, Sugiyama K, Fujii M, Yamauchi H, Nakao A, de Crombrugghe B, Watanabe T, Okazaki I. 2003. Interferon alpha down-regulates collagen gene transcription and suppresses experimental hepatic fibrosis in mice. Hepatology 38: 890-899.
13. Ji JF, Shi J, Budhu A, Yu ZP, Forgues M, Roessler S, Ambs S, Chen YD, Meltzer PS, Croce CM, Qin LX, Man K, Lo CM, Lee J, Ng IOL, Fan J, Tang ZY, Sun HC, Wang XW. 2009a. MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 361: 1437-1447.
14. Ji JL, Zhang JS, Huang GC, Qian J, Wang XQ, Mei S. 2009b. Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett 583: 759-766.
15. Katayama T, Nakanishi K, Nishihara H, Kamiyama N, Nakagawa T, Kamiyama T, Iseki K, Tanaka S, Todo S. 2007. Type I interferon prolongs cell cycle progression via p21(WAF1/CIP1) induction in human colon cancer cells. Int J Oncol 31: 613-620.
16. Liu Q, Fu HJ, Sun F, Zhang HM, Tie Y, Zhu J, Xing RY, Sun ZX, Zheng XF. 2008. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36: 5391-5404.
17. Mallat A, Preaux AM, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P. 1995. Interferon alpha and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21: 1003-1010.
18. Nevzorova YA, Bangen JM, Gassler N, Haas U, Weiskirchen R, Tacke F, Sicinski P, Trautwein C, Liedtke C. 2010. Cyclin E1 controls the cell cycle activity of hepatic stellate cells and triggers fibrogenesis in mice. J Hepatol 52: S374-S375.
19. Ogawa T, Kawada N, Ikeda K. 2009. Effect of natural interferon alpha on proliferation and apoptosis of hepatic stellate cells. Hepatol Int 3: 497-503.
20. Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. 2010. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun 391: 316-321.
21. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. 2007. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449: 919-922.
22. Pestka S, Langer JA, Zoon KC, Samuel CE. 1987. Interferons and their actions. Annu Rev Biochem 56: 727-777.
23. Russell-Harde D, Wagner TC, Perez HD, Croze E. 1999. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation. Biochem Biophys Res Commun 255: 539-544.
24. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grander D. 1999. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Oncogene 18: 2798-2810.
25. Shen H, Zhang M, Minuk GY, Gong YW. 2002. Different effects of rat interferon alpha, beta and gamma on rat hepatic stellate cell proliferation and activation. BMC Cell Biol 3: 9.
26. Tanabe J, Izawa A, Takemi N, Miyauchi Y, Torii Y, Tsuchiyama H, Suzuki T, Sone S, Ando K. 2007. Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects. Immunology 122: 562-570.
27. Uyama N, Zhao L, Van Rossen E, Hirako Y, Reynaert H, Adams DH, Xue Z, Li Z, Robson R, Pekny M, Geerts A. 2006. Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut 55: 1276-1289.
28. Uze G, Schreiber G, Piehler J, Pellegrini S. 2007. The receptor of the type I interferon family. Curr Top Microbiol Immunol 316: 71-95.
29. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, Zern MA. 2010. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 298: G101-G106.
30. Wang F, Fu XD, Zhou Y, Zhang Y. 2009. Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep 42: 725-730.
31. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ. 2005. Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis. Gut 54: 142-151.
32. Xu T, Zhu Y, Xiong YJ, Ge YY, Yun JP, Zhuang SM. 2009. MicroRNA-195 suppresses tumorigenicity and regulates G(1)/S transition of human hepatocellular carcinoma cells. Hepatology 50: 113-121.